Vivo Bio Tech Ltd.
Snapshot View

28.95 +0.25 ▲0.9%

03 February 2023, 04:01:00 PM
Volume: 9,673

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website
Market Cap 43.15 Cr.
Enterprise Value(EV) 105.87 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 0.75 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 38.45 Trailing Twelve Months Ending 2022-09
Industry PE 32.22 Trailing Twelve Months Ending 2022-09
Book Value / Share 33.04 Trailing Twelve Months Ending 2022-09
Price to Book Value 0.88 Calculated using Price: 28.95
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.49 Cr. 14,903,520 Shares
FaceValue 10
Company Profile
Vivo Bio Tech was incorporated on February 12, 1987 as Golden Growth Fund, Hyderabad-based Vivo Bio Tech (VBTL) is a contract research company engaged in biotechnology and pharma drug discovery activities. The company was converted into a public limited company from Jun. 19, 1992. VBTL provides services ranging from insilico design, wet lab contract research, preclinical research and clinical studies spanning the entire drug discovery value chain.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.87%
1 Week
-1.03%
1 Month
-3.34%
3 Month
-21.54%
6 Month
-9.95%
1 Year
-56.89%
2 Year
-46.49%
5 Year
-38.79%
10 Year
+104.30%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 3.52 5.25 9.48 22.17 21.01 10.21 14.85 15.36 5.06
Return on Capital Employed (%) 7.95 4.72 5.96 12.39 15.18 9.58 13.85 18.81 9.32
Return on Assets (%) 0.75 1.14 2.09 5.17 5.64 3.92 7.58 8.02 2.18

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 9 9 10 13 19 27 33 43 47 50
Non Curr. Liab. 5 4 15 22 15 9 9 15 52 50
Curr. Liab. 26 28 20 17 25 19 21 22 23 23
Minority Int.
Equity & Liab. 40 41 46 51 60 55 62 80 122 122
Non Curr. Assets 21 20 24 32 32 30 35 52 96 94
Curr. Assets 19 22 22 20 28 25 27 27 26 28
Misc. Exp. not W/O 0 0 0 0 0 0 0 0 0
Total Assets 40 41 46 51 60 55 62 80 122 122

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 16 18 29 34 47 56 55 52 51 52
Other Income 1 1 1 0 0 0 0 0 0 0
Total Income 17 19 29 35 47 56 55 52 51 52
Total Expenditure -14 -15 -25 -27 -36 -46 -43 -34 -35 -35
PBIDT 3 4 5 8 11 10 13 18 16 17
Interest 0 -1 0 -1 -2 -3 -3 -4 -4 -6
Depreciation -2 -3 -3 -4 -5 -5 -5 -6 -7 -9
Taxation 0 0 0 0 -1 0 0 -3 -2 -1
Exceptional Items
PAT 0 0 1 3 3 2 4 6 2 1
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 0 0 1 3 3 2 4 6 2 1
Adjusted EPS 0 0 1 3 3 2 3 4 2 1

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 2 3 2 9 -6 11 -1 9 14 14
Cash Fr. Inv. 25 -1 -2 -7 -12 -5 -4 -10 -23 -51
Cash Fr. Finan. -19 0 -1 0 7 -3 1 2 9 38
Net Change 8 1 -1 1 -11 3 -4 0 0 1
Cash & Cash Eqvt 10 11 11 12 1 4 1 1 1 2

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 34.70 36.58 39.84 39.84 39.84 39.67 42.16 42.16 42.16
Public 65.30 63.42 60.16 60.16 60.16 60.33 57.84 57.84 57.84
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 30 Jan 2023
Board Meeting Intimation for Un-Audited Standalone & Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2022.
VIVO BIO TECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve the Un-Audited Standalone & Consolidated Financial Results of the Company for the Quarter and Nine Months ended December 31 2022.
Tue, 10 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Vivo Bio Tech Limited has submitted with the exchange the certificate received from M/s. Aarthi Consultants Private Limited (Registrar and Share Transfer Agent) for the period from October 01 2022 to December 31 2022 under SEBI (Depositories and Participants) Regulations 2018.
Wed, 04 Jan 2023
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Vivo Bio Tech Limited has informed the exchange that the Company has today allotted 27 000 Equity Shares under Vivo Bio Employees Stock Option Scheme 2016 to the eligible employees of the Company pursuant to the exercise of options granted.Consequently the issued and Subscribed Share Capital of the Company stands increased to Rs. 14 90 35 200 divided into 1 49 03 520 Equity Shares of Rs.10/- each.

Technical Scans View Details >>

Fri, 03 Feb 2023
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease in 3 Months High Decrease in 3 Months
High Decrease in 1 Year High Decrease in 1 Year
Closing Near 20 SMA Closing Near 20 SMA

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 246,567.66 1,027.65 +2.0%
Cipla Ltd. 82,812.97 1,026.00 +0.1%
Divi's Laboratories Ltd. 76,573.08 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. 72,577.66 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. 61,039.46 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. 52,289.82 1,545.00 +0.3%
Abbott India Ltd. 44,198.55 20,800.00 +1.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 58.54 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-12 31.39 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 25.59 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.92 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.70 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.92 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-09 50.12 20,800.00 +1.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.46 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-12 3.65 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 6.31 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.30 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.20 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.20 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-09 16.28 20,800.00 +1.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 0.00 20,800.00 +1.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 20,800.00 +1.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 20,800.00 +1.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,800.00 +1.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 798.70 20,800.00 +1.5%

FAQ's On Vivo Bio Tech Ltd.

What is Vivo Bio Tech share price?

Can I buy Vivo Bio Tech shares now?

What is the Market Cap of Vivo Bio Tech?

What are the key metrics to analyse Vivo Bio Tech?

What is the 52 Week High and Low of Vivo Bio Tech?

What is the trend of Vivo Bio Tech share price?